ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 62 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $43,600 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,355,925 | $2,955,917 | 2.56% |
| Susquehanna International Group Ltd. | 113,526 | $247,487 | 0.14% |
| XTX Topco Ltd | 151,620 | $330,532 | 0.07% |
| Corsair Capital Management | 47,256 | $103,018 | 0.04% |
| Diametric Capital, LP | 14,314 | $31,205 | 0.02% |
| Draper Asset Management, LLC | 5,320 | $11,598 | 0.02% |
| ETF MANAGERS GROUP, LLC | 68,940 | $150,289 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $12,267 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 506,255 | $1,103,636 | 0.00% |
| Apollon Wealth Management, LLC | 20,000 | $43,600 | 0.00% |